Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Barbui

Showing results (271-280 of 380) with videos related to

Pageof 38
Sort By:
The American Journal of Medicine|April 1, 1990
Hemostatic complications in young patients with essential thrombocythemiaA J Mitus, T Barbui, L N Shulman, et al.
Blood|June 25, 1998
Cancer procoagulant and tissue factor are differently modulated by all-trans-retinoic acid in acute promyelocytic leukemia cellsA Falanga, R Consonni, M Marchetti, et al.
Thrombosis and Haemostasis|February 12, 1998
The effect of very-low-dose warfarin on markers of hypercoagulation in metastatic breast cancer: results from a randomized trialA Falanga, M N Levine, R Consonni, et al.
Annals of the Rheumatic Diseases|March 1, 1993
Cutaneous manifestations associated with antiphospholipid antibodies in patients with suspected primary antiphospholipid syndrome: a case-control studyL Naldi, F Locati, L Marchesi, et al.
Leukemia|June 22, 1999
Primary effusion lymphoma after heart transplantation: a new entity associated with human herpesvirus-8G Dotti, R Fiocchi, T Motta, et al.
Leukemia|July 6, 2013
Elevated C-reactive protein is associated with shortened leukemia-free survival in patients with myelofibrosisT Barbui, A Carobbio, G Finazzi, et al.
Blood|August 1, 1995
Loss of blast cell procoagulant activity and improvement of hemostatic variables in patients with acute promyelocytic leukemia administered all-trans-retinoic acidA Falanga, L Iacoviello, V Evangelista, et al.
Thrombosis Research|December 1, 1991
A common point mutation producing type 1A antithrombin III deficiency: AT129 CGA to TGA (Arg to Stop)R J Olds, D A Lane, H Ireland, et al.
Leukemia|June 16, 2006
Blood oxidative status and selectins plasma levels in healthy donors receiving granulocyte-colony stimulating factorG Cella, M Marchetti, A Vignoli, et al.
Hematological Oncology|January 1, 1985
Treatment of acute lymphoblastic leukemia in adultsT Barbui, R Bassan, T Chisesi, et al.
Pageof 38

Showing results (271-280 of 380) with videos related to

Sort By:
Pageof 38
The American Journal of Medicine|April 1, 1990
Hemostatic complications in young patients with essential thrombocythemiaA J Mitus, T Barbui, L N Shulman, et al.
Blood|June 25, 1998
Cancer procoagulant and tissue factor are differently modulated by all-trans-retinoic acid in acute promyelocytic leukemia cellsA Falanga, R Consonni, M Marchetti, et al.
Thrombosis and Haemostasis|February 12, 1998
The effect of very-low-dose warfarin on markers of hypercoagulation in metastatic breast cancer: results from a randomized trialA Falanga, M N Levine, R Consonni, et al.
Annals of the Rheumatic Diseases|March 1, 1993
Cutaneous manifestations associated with antiphospholipid antibodies in patients with suspected primary antiphospholipid syndrome: a case-control studyL Naldi, F Locati, L Marchesi, et al.
Leukemia|June 22, 1999
Primary effusion lymphoma after heart transplantation: a new entity associated with human herpesvirus-8G Dotti, R Fiocchi, T Motta, et al.
Leukemia|July 6, 2013
Elevated C-reactive protein is associated with shortened leukemia-free survival in patients with myelofibrosisT Barbui, A Carobbio, G Finazzi, et al.
Blood|August 1, 1995
Loss of blast cell procoagulant activity and improvement of hemostatic variables in patients with acute promyelocytic leukemia administered all-trans-retinoic acidA Falanga, L Iacoviello, V Evangelista, et al.
Thrombosis Research|December 1, 1991
A common point mutation producing type 1A antithrombin III deficiency: AT129 CGA to TGA (Arg to Stop)R J Olds, D A Lane, H Ireland, et al.
Leukemia|June 16, 2006
Blood oxidative status and selectins plasma levels in healthy donors receiving granulocyte-colony stimulating factorG Cella, M Marchetti, A Vignoli, et al.
Hematological Oncology|January 1, 1985
Treatment of acute lymphoblastic leukemia in adultsT Barbui, R Bassan, T Chisesi, et al.
Pageof 38